# Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

> **NCT00311428** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 270 (—)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza

## Key facts

- **NCT ID:** NCT00311428
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 270 (—)
- **Last updated:** 2006-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311428, "Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00311428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*